Serum S100β protein as a marker of disease activity in patients with malignant melanoma

Medical Oncology

Volumn 18, Issue 2, 2001, Pages 109-120

  Mohammed, Muneeruddin Q ^a   Abraha, Hagosa D ^b   Sherwood, Roy A ^b   MacRae, Kenneth ^c   Retsas, Spyros ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

LDH; Melanoma; Metastatic; Prognosis; S100; Serum; Treatment; Tumor markers

Indexed keywords

ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; PROTEIN; PROTEIN S100BETA; TUMOR MARKER; UNCLASSIFIED DRUG; PROTEIN S 100; S100A1 PROTEIN;

ADULT; ARTICLE; CALCULATION; CANCER SURVIVAL; DIAGNOSTIC IMAGING; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; AGED; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; DISEASE PROGRESSION; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034741241     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:18:2:109     Document Type: Article

References (20)

1. Perspectives on S-100 protein biology
2. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application
3. S-100 protein as a marker for melanocytic and other tumours
4. Melanoma-associated antigens
5. 2nd International Conference on the Adjuvant Therapy of Malignant Melanoma. London, UK, 14-15 March, 1997. Report and abstracts
6. Clinical significance of serum S 100 in metastatic malignant melanoma
7. Serum S-100 protein: A potentially useful prognostic marker in cutaneous melanoma
8. Clinical and prognostic relevance of serum S100β protein in malignant melanoma
9. Serum S 100 - A marker for disease monitoring in metastatic melanoma
10. Chemotherapy of malignant melanoma; the European experience
11. Strategies for improving survival in malignant melanoma: Focus on Vindesine
12. Taxol and vinorelbine: A new active combination for disseminated malignant melanoma
13. Systemic Treatment of malignant melanoma: Grade is as important as stage
14. Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients
15. Serum S-100 protein, relationship to clinical outcome in acute stroke
16. Serial S100 protein serum measurements related to early magnetic resonance imaging after minor head injury
17. Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma
18. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
19. A new American Joint Committee on Cancer Staging System for cutaneous melanoma
20. Serum S-100 protein as a prognostic marker in malignant cutaneous melanoma